Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 18.02 | -39.04 |
PEG Ratio (TTM) | -0.02 | -2.14 |
P/S Ratio (TTM) | 11.03 | 51.80 |
P/B Ratio (TTM) | 0.14 | 16.01 |
P/FCF Ratio (TTM) | -72.74 | -212.22 |
Price to 5YR AVG Earnings Ratio | N/A | -39.32 |
Price to 5YR AVG FCF Ratio | N/A | -27.27 |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.71% | 40.55% |
ROE (TTM) | 0.76% | -488.55% |
Net Profit Margin (TTM) | 17.90% | -358.55% |
ROIC 5YR AVG | N/A | 791.01% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -520.40% | -398.10% | N/A |
Revenue | 32.52% | 9,939,704.11% | N/A |
Net Income | -180.37% | -1,385.54% | N/A |
Cash Flow | -277.26% | -150.01% | N/A |
Health (28%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.03 | 2.52 |
Quick Ratio (TTM) | 0.01 | 44.73 |
D/E Ratio (TTM) | 0.01 | 0.17 |
Interest Coverage (TTM) | 1.20 | 3.61 |
Piotroski F-Score | 4 | 3 |
Altman Z-Score | N/A | 21.93 |
LTL to 5YR AVG FCF | N/A | -0.68 |
Shares Outstanding Growth 5YR AVG | N/A | 488.34% |